With ViaOpta Nav, visually impaired people can now use Apple watches and Android Wear devices to navigate to and from places with greater ease.
The winners of the fifth annual Novartis International BioCamp embarked on a trip to discover China, the prize for winning the BioCamp 2014 student competition.
On January 28, 2015, we published our 2014 Annual Report – including a comprehensive look back at our results and achievements in Corporate Responsibility during the year.
Just as generic drugs have dramatically lowered the price of some common medicines and expanded access to them, so follow-on versions of complex biologic drugs to treat diseases like cancer and multiple sclerosis could benefit patients and reduce costs.
Novartis collaborates with others to help address some of the world’s greatest health challenges. Our corporate responsibility programs help more people secure the healthcare they need, regardless of where they live.
As the Ebola outbreak in West Africa continues to expand with isolated cases now being reported in Europe and North America, Novartis and its employees are contributing aid and pursuing research to help fight the deadly virus.
Interview with Mahesh P. Karande, Head of the Africa Cluster for Novartis. In this role, he is responsible for leading Novartis business activities in sub-Saharan Africa.
How Novartis is working towards the elimination of leprosy across the world with partners such as the World Health Organization (WHO) by donating multidrug therapy (MDT) to treat leprosy patients globally.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society report.
This site is intended for a global audience.